News
Globally, it was estimated that approximately 4.95 million people died from Antimicrobial Resistance-related causes in 20191. And yet, one in three adults doesn’t understand what this term means2. Faced with this alarming situation, an awareness-raising campaign encourages the general public to change their behaviour with regard to the use of antibiotics. Indeed, each person, at their own level, has a role to play to preserve their effectiveness.
Swipe to discover more
-
Third-Quarter 2024 Business Review
bioMérieux, a world leader in the field of in vitro diagnostics, today releases its business review for the nine months ended September 30, 2024: Consolidated sales amounted to €2,871 million, representing an organic growth of +10.3% at constant exchange rates and scope of consolidation. -
Advancing Antimicrobial Stewardship in Emergency Care: how diagnostics can change the game.
Antimicrobial resistance (AMR) has been identified as an increasing threat to modern medicine, leading to higher treatment costs and increased morbidity and mortality.1 The misuse of broad-spectrum antibiotics is a major contributor to the rise of AMR — particularly in emergency care, where studies have estimated that 40% to 60% of antibiotics are inappropriately prescribed.2 To understand the cause of this disparity, it is important to provide context on the many unique facets of the emergency department, while exploring how comprehensive antimicrobial stewardship could improve prescribing practices. -
bioMérieux and St James’s Hospital in Ireland announce the world-first Data & IT Centre of Reference partnership
On November 14th, 2024, bioMérieux officially launched its first Data & IT Centre of Reference partnership with St James's Hospital in Dublin, Ireland. This landmark collaboration has been celebrated with an event held at the Davis Coakley Lecture Theatre, St James's Hospital.
Enabling Decision-Making
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19